LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42 | -51.2% | 39,189 | +4.0% | 0.00% | – |
| Q2 2023 | $86 | -16.5% | 37,669 | -10.9% | 0.00% | – |
| Q1 2023 | $103 | +145.2% | 42,296 | +89.2% | 0.00% | – |
| Q4 2022 | $42 | -99.5% | 22,360 | +533.2% | 0.00% | – |
| Q3 2022 | $8,000 | -94.3% | 3,531 | -95.3% | 0.00% | – |
| Q2 2022 | $140,000 | -20.0% | 75,254 | -9.6% | 0.00% | – |
| Q1 2022 | $175,000 | -73.9% | 83,237 | -51.0% | 0.00% | – |
| Q4 2021 | $670,000 | +400.0% | 169,940 | +512.5% | 0.00% | – |
| Q3 2021 | $134,000 | +123.3% | 27,747 | +109.4% | 0.00% | – |
| Q2 2021 | $60,000 | -75.4% | 13,250 | -68.2% | 0.00% | – |
| Q1 2021 | $244,000 | +430.4% | 41,628 | +211.1% | 0.00% | – |
| Q4 2020 | $46,000 | +70.4% | 13,380 | -30.2% | 0.00% | – |
| Q3 2020 | $27,000 | -90.6% | 19,159 | -86.6% | 0.00% | – |
| Q2 2020 | $287,000 | +105.0% | 143,029 | +100.1% | 0.00% | – |
| Q1 2020 | $140,000 | -42.9% | 71,479 | +20.9% | 0.00% | – |
| Q4 2019 | $245,000 | +206.2% | 59,104 | +121.3% | 0.00% | – |
| Q3 2019 | $80,000 | -54.0% | 26,704 | -3.8% | 0.00% | – |
| Q2 2019 | $174,000 | +34.9% | 27,754 | +19.1% | 0.00% | – |
| Q1 2019 | $129,000 | +545.0% | 23,310 | +701.9% | 0.00% | – |
| Q4 2018 | $20,000 | -91.8% | 2,907 | -87.3% | 0.00% | – |
| Q3 2018 | $244,000 | +351.9% | 22,949 | +414.1% | 0.00% | – |
| Q2 2018 | $54,000 | -69.0% | 4,464 | -78.0% | 0.00% | – |
| Q1 2018 | $174,000 | -73.2% | 20,264 | -69.2% | 0.00% | – |
| Q4 2017 | $649,000 | +35.2% | 65,745 | +68.3% | 0.00% | – |
| Q3 2017 | $480,000 | -56.0% | 39,071 | -41.0% | 0.00% | -100.0% |
| Q2 2017 | $1,091,000 | +496.2% | 66,248 | +420.4% | 0.00% | – |
| Q1 2017 | $183,000 | -57.6% | 12,730 | -59.2% | 0.00% | – |
| Q4 2016 | $432,000 | +575.0% | 31,214 | +769.2% | 0.00% | – |
| Q3 2016 | $64,000 | -98.6% | 3,591 | -98.9% | 0.00% | -100.0% |
| Q2 2016 | $4,624,000 | +13500.0% | 322,216 | +10440.3% | 0.01% | – |
| Q1 2016 | $34,000 | -99.5% | 3,057 | -99.4% | 0.00% | -100.0% |
| Q4 2015 | $6,632,000 | +2110.7% | 510,186 | +1594.9% | 0.01% | – |
| Q3 2015 | $300,000 | +4900.0% | 30,101 | +3676.8% | 0.00% | – |
| Q2 2015 | $6,000 | – | 797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
| Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
| MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
| Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
| FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
| WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
| HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |